Vimarsana
Biggest News Aggregation in the World

Page 16 - Mark Eisner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Eisner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Eisner Today - Breaking & Trending Today

Settlement reached in dispute over $750,000 left to Anne Arundel SPCA - Vimarsana News

Settlement reached in dispute over $750,000 left to Anne Arundel SPCA

The SPCA has agreed to take $350,000 after the organization initially fought to retain the entirety of a $750,000 donation left to them by a former board member who died in 2007.

FibroGen Inc (FGEN) Q1 2021 Earnings Call Transcript - Vimarsana News

FibroGen Inc (FGEN) Q1 2021 Earnings Call Transcript

FibroGen Inc (FGEN) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. FibroGen Inc (NASDAQ: FGEN) Operator Good day, and welcome. Thank you for standing by. Welcome to the FibroGen First Quarter 2021 Financial Results Conference Call. [Operator Instructions] After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to your speaker for today, Mr. Michael Tung. Please go ahead.SPONSORED: 10 stocks we like better than Fi...

Source: msn.com
FibroGen Receives Rare Pediatric Disease Designation from the U.S. FDA for Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy - Vimarsana News

FibroGen Receives Rare Pediatric Disease Designation from the U.S. FDA for Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy

FibroGen Receives Rare Pediatric Disease Designation from the U.S. FDA for Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy April 15, 2021 07:00 ET | Source: FibroGen, Inc FibroGen, Inc San Francisco, California, UNITED STATES SAN FRANCISCO, April 15, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) Designation for the company’s anti-CTGF antibody, pamrevlumab, for the treatment of patients with Duchenne muscular dystrophy (DMD)....

Crimson tide - Newspaper - DAWN.COM - Vimarsana News

Crimson tide - Newspaper - DAWN.COM

Mahir Ali PABLO Neruda was already something of a renowned poet when he was posted as the Chilean consul to Barcelona in 1934, and shortly afterwards transferred to Madrid, a vantage point from where he witnessed the unfolding Spanish civil war. It proved to be a thoroughly politicising experience. He did not need to be pressured to pick sides in that conflict. Like the towering American singer Paul Robeson, he had no choice. The Franco fascists claimed the life of his close friend Federico Garcia Lorca. Other comrades fought at the front. Neruda published a volume of verse titled Spain in My...

Source: dawn.com
FibroGen Inc (FGEN) Q4 2020 Earnings Call Transcript - Vimarsana News

FibroGen Inc (FGEN) Q4 2020 Earnings Call Transcript

Operator Ladies and gentlemen, thank you for standing by, and welcome to the FibroGen Fourth Quarter and Full Year 2020 Financial Results Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Mr. Michael Tung. Thank you. Please go ahead, sir. Michael Tung -- Vice President of Corporate Strategy and Investor Relations Thank you, Linda and good afternoon, everyone. I'm Michael Tung, Vice President of Corporate Strategy and Investor Relations at FibroGen. Joining me on today's are Enrique Conterno, our Chief Executive Officer; Dr. Percy Car...

Source: fool.com